![Andy de Deene](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andy de Deene
Företagsledare/Principal på
OXURION NV
Profil
Dr. Andy de Deene is a Chief Development Officer at Oxurion NV.
Dr. de Deene was previously employed as a Director & Manager by The Janssen Research Foundation and a Director & Manager by Xcellentis NV.
He received his graduate degree from Universität zu Köln, a graduate degree from Ghent University, an MBA from Vlerick Leuven Gent Management School and a doctorate degree from Ghent University.
Aktiva positioner av Andy de Deene
| Företag | Position | Start |
|---|---|---|
| OXURION NV | Företagsledare/Principal | 2008-06-01 |
Tidigare kända positioner av Andy de Deene
| Företag | Position | Slut |
|---|---|---|
Xcellentis NV
 Xcellentis NV Pharmaceuticals: MajorHealth Technology Develops clinical stage pipeline products for the treatment of chronic, hard-to-heal wounds | Direktör/Styrelseledamot | - |
The Janssen Research Foundation | Direktör/Styrelseledamot | - |
Andy de Deenes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
21
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
 Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxurion NV
 Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
Xcellentis NV
Xcellentis NV Pharmaceuticals: MajorHealth Technology Develops clinical stage pipeline products for the treatment of chronic, hard-to-heal wounds | Health Technology |
The Janssen Research Foundation |
